U.S. exceeds 400,000 coronavirus deaths The U.S. coronavirus death toll topped 400,000 on Tuesday, according to a Reuters tally, as the country hardest hit by the pandemic struggled to meet the demand for vaccines to stem the spread of infection. Anurag Maan, Roshan Abraham U.S.

(Reuters) - The U.S. coronavirus death toll topped 400,000 on Tuesday, according to a Reuters tally, as the country hardest hit by the pandemic struggled to meet the demand for vaccines to stem the spread of infection.

Conspiracies thrive in U.K. as as doctors struggle with Covid variant "In the U.K., we can look at the U.S. and take that as a warning sign of where things may be heading," one misinformation expert said. NBC News

LONDON — British front-line workers who were applauded on doorsteps in the early weeks of the pandemic now confront a torrent of polarization and misinformation.

As the COVID-19 vaccine rolls out, three big questions loom. First, can someone who has been vaccinated still spread the disease? Second, will the vaccine remain effective as the virus itself evolves? And third, how long will the vaccine's protection last?

Answers to these questions lie in our immune systems. And the answers aren't straightforward because our immune systems are both remarkably adept and remarkably challenging to predict.

...the first question, about whether people who are vaccinated can still spread the disease. Marion Pepper, an immunologist at the University of Washington, says that's not just an open question for this vaccine, but for vaccines in general.

EU kicks off debate on vaccine travel certificates European Union countries kicked off a debate on Monday on whether people who have received a COVID-19 vaccine should have greater freedom to travel in the summer than those not immunized. Philip Blenkinsop U.S.

BRUSSELS (Reuters) - European Union countries kicked off a debate on Monday on whether people who have received a COVID-19 vaccine should have greater freedom to travel in the summer than those not immunized.

A new COVID-19 challenge: Mutations rise along with cases The race against the virus that causes COVID-19 has taken a new turn: Mutations are rapidly popping up, and the longer it takes to vaccinate people, the more likely it is that a variant that can... AP NEWS

The race against the virus that causes COVID-19 has taken a new turn: Mutations are rapidly popping up, and the longer it takes to vaccinate people, the more likely it is that a variant that can elude current tests, treatments and vaccines could emerge.

Israeli hospital: 98% of staff who got 2nd shot have high-level COVID antibodies * * * timesofisrael

A new serological study conducted at Sheba Medical Center in Ramat Gan has shown 98% of hospital workers who received the second dose of the coronavirus vaccine have developed a high level of antibodies to fight off the virus.

Latest on worldwide spread of the coronavirus The world is on the brink of "catastrophic moral failure" in sharing COVID-19 vaccines, the head of the World Health Organization said, urging countries and manufacturers to spread doses more fairly. Reuters Staff U.S.

France is on track to reach its target of vaccinating 1 million people by the end of January and has enough doses to increase the total to 2.4 million by the end of February.

Fauci says new vaccines could be ready for possible approval within weeks, not months Amid frustration and delays of administering current vaccines, Fauci said President-elect Biden's goal of 100 million doses in 100 days is achievable. NBC News

WASHINGTON — Dr. Anthony Fauci, one of the nation’s foremost public health experts, said Sunday that the U.S. is “weeks away, not months away” from considering the approval of new coronavirus vaccines.